Written by KFF’s Tricia Neuman, Juliette Cubanski, and Larry Levitt, this article in Health Affairs Forefront explores the implications of the inaugural Medicare drug price negotiations, detailing the savings they will provide for both the government and Medicare recipients. Additionally, the piece considers how candidates’ perspectives on this topic may influence the upcoming elections and the future of drug price negotiations by the government.